VNS and DBSResearch Radar
Understanding the brain’s reward system in deep brain stimulation for depression
For patients with treatment-resistant depression (TRD) — those who do not respond to multiple antidepressant trials — deep brain stimulation (DBS) offers an option…
By João L. de Quevedo, MD, PhD
Published on · Last reviewed on · 2 min read
For patients with treatment-resistant depression (TRD) — those who do not respond to multiple antidepressant trials — deep brain stimulation (DBS) offers a promising, yet still experimental, option. Recent research published in Molecular Psychiatry explores how brain activity within the reward circuit relates to treatment outcomes following DBS targeting the ventral anterior limb of the internal capsule (vALIC).
What did the researchers study?
The reward circuit, which includes the nucleus accumbens (NAc), caudate nucleus, and midcingulate cortex, regulates how we experience pleasure and motivation — functions often impaired in depression. Researchers at Amsterdam UMC investigated whether brain activity in these regions could predict who benefits most from vALIC DBS.
Fifteen patients with severe TRD underwent functional magnetic resonance imaging (fMRI) before and after DBS surgery, performing a task that simulated winning or losing money. The team compared their brain activity with that of healthy volunteers and examined how reward processing changed after DBS treatment.
Key findings
- Baseline brain activity predicted outcomes:
Patients with lower NAc activation during “loss anticipation” and higher caudate and midcingulate activation during “reward feedback” tended to have poorer treatment outcomes.
- DBS improved symptoms but did not alter overall reward processing:
Although patients showed a significant reduction in depression severity, their overall brain reward responses did not differ significantly from those of healthy controls after treatment.
- A new clue emerged:
Those who showed greater activation in the middle frontal gyrus (MFG) after DBS — an area involved in decision-making and emotional regulation — showed greater clinical improvement.
Why this matters
These results suggest that individual differences in reward circuit function may help explain why some patients benefit from DBS and others do not. The results also highlight the middle frontal gyrus as a potential biomarker or complementary target for future interventions, possibly linking DBS outcomes to noninvasive neuromodulation therapies, such as repetitive transcranial magnetic stimulation (rTMS).
As we move toward precision psychiatry, understanding these brain-based predictors may one day help clinicians personalize interventional treatments, improving response rates for those struggling with refractory depression.
Related content
VNS and DBS
Long-term benefit in the most difficult cases of depression: new evidence supporting vagus nerve stimulation
Achieving improvement in treatment-resistant depression (TRD) is difficult — but maintaining that improvement over time is often even more challenging. Patients with marked levels of resistance…
· Research Radar
ECT
At the Bedside: How Electroconvulsive Therapy at UTHealth Houston Helped One Woman Reclaim Her Life
Written by: Taylor Medlin Karen Vine Fuller takes a photo with João de Quevedo, MD, PhD, before beginning her electroconvulsive therapy....
· Article
VNS and DBS
Unlocking Hope Through Deep Brain Stimulation for Treatment-Resistant Depression
Depression, with its suffocating grip on the mind, is a relentless adversary for millions of people worldwide. Despite...
· Article